Comparison between Anu's Laboratories IPO and Bafna Pharmaceuticals IPO.
Anu's Laboratories IPO is a Mainboard Fixed Price IPO proposed to list at BSE while Bafna Pharmaceuticals IPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Anu's Laboratories IPO is up to ₹80.22 Cr whereas the issue size of the Bafna Pharmaceuticals IPO is up to ₹25.60 Cr. The final issue price of Anu's Laboratories IPO is ₹210.00 per share and of Bafna Pharmaceuticals IPO is ₹40.00 per share.
| Anu's Laboratories IPO | Bafna Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | |
| Issue Price (Upper) | ₹210.00 per share | |
| Issue Price (Final) | ₹210.00 per share | ₹40.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 30 shares | |
| Fresh Issue Size | 38,20,000 shares | 64,00,206 shares |
| Fresh Issue Size (Amount) | up to ₹80.22 Cr | up to ₹25.60 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,20,000 shares | 64,00,206 shares |
| Issue Size Total (Amount) | up to ₹80.22 Cr | up to ₹25.60 Cr |
Anu's Laboratories IPO opens on May 12, 2008, while Bafna Pharmaceuticals IPO opens on May 27, 2008. The closing date of Anu's Laboratories IPO and Bafna Pharmaceuticals IPO is May 15, 2008, and May 30, 2008, respectively.
| Anu's Laboratories IPO | Bafna Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 12, 2008 | May 27, 2008 |
| Issue Close | May 15, 2008 | May 30, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 04, 2008 | Jun 27, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Anu's Laboratories IPO P/E ratio is , as compared to Bafna Pharmaceuticals IPO P/E ratio of .
| Anu's Laboratories IPO | Bafna Pharmaceuticals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 74.79 | 71.07 | ||||
| Promoter Shareholding (Post-Issue) | 51.13 | 42.6 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹253.60 Cr. | ₹63.92 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 |
In the Anu's Laboratories IPO Retail Individual Investors (RII) are offered 12,67,000 shares while in Bafna Pharmaceuticals IPO retail investors are offered 12,67,000 shares. Qualified Institutional Buyers (QIB) are offered 18,10,000 shares in Anu's Laboratories IPO and in Bafna Pharmaceuticals IPO.
| Anu's Laboratories IPO | Bafna Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 18,10,000 shares | |
| NII | 5,43,000 shares | 32,00,000 shares |
| RII | 12,67,000 shares | 32,00,000 shares |
| Employee | 2,00,000 shares | |
| Others | ||
| Total | 38,20,000 shares | 64,00,000 shares |
Anu's Laboratories IPO subscribed 8.43x in total, whereas Bafna Pharmaceuticals IPO subscribed 4.88x.
| Anu's Laboratories IPO | Bafna Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 2.84x | |
| NII (times) | 26.97x | 1.57x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 9.64x | 8.20x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 8.43x | 4.88x |
